New & Noteworthy

December 2020

Central Precocious Puberty Treatment

Arbor Pharmaceuticals, LLC (part of Azurity Phamaceuticals)

Arbor Pharmaceuticals, a specialty pharmaceutical company, announces the availability of Triptodur (triptorelin), an FDA-approved, twice-yearly injectable gonadotropin-releasing hormone agonist (GnRHa) for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP). Arbor Pharmaceuticals confirms an ample supply with additional product on order.

Arbor Pharmaceuticals, LLC

Request More Information

Current Issue